We examined the exomes of four patients diagnosed with estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative DCIS, and synchronous IBC after surgical excision. Here, ERBB2 is linked to ductal breast carcinoma in situ.